TMCnet News
European Market Report for Hysterosalpingography Catheters 2016 - MedCore - Research and MarketsResearch and Markets has announced the addition of the "European Market Report for Hysterosalpingography Catheters 2016 - MedCore" report to their offering. Unit sales are expected to increase during the forecast period due to increases in procedure rates. As HSG catheters are often used to test female fertility, the projected increases in unit sales correspond to the increases in fertility treatments. Fertility treatments are becoming more common as the average age of pregnancy has increased substantially. As women continue to delay pregnancy, the need for fertility treatments is projected to increase. Hysterosalpingography (HSG) catheters, also known as HS catheters, are used for hysterosalpingography and sonohysterography procedures. These devices are used by practitioners to inject either a contrast media or sterile saline into the uterine cavity and fallopian tubes through the cervical opening These procedures are used to evaluate infertility, pregnancy loss, uterine bleeding or menstrual disorders, and to asses tubal patency and uterine pathology. Hysterosalpingography (HSG) requires the infusion of radiographic contrast dye via the HSG catheter. This radiologic procedure uses X-rays to determine if there are blockages in the fallopian tubes and where they may be located as the dye travels through the reproductive tract. Sonohysterography, on the other hand, uses sterile saline to help render images of the uterus and any abnormalities with the aid of a transabdominal ultrasound. Key Topics Covered:
1. Research Methodology 2. Country Profiles 3. Hysterosalpingography Catheter Market Companies Mentioned
For more information about this report visit http://www.researchandmarkets.com/research/9sf4bb/european_market View source version on businesswire.com: http://www.businesswire.com/news/home/20170421005352/en/ |
